Search Results - R. Harkes
- Showing 1 - 3 results of 3
-
1
Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer by I. Nederlof, S. Hajizadeh, F. Sobhani, S. E. A. Raza, K. AbdulJabbar, R. Harkes, M. J. van de Vijver, R. Salgado, C. Desmedt, M. Kok, Y. Yuan, H. M. Horlings
Published in npj Breast Cancer (2022-04-01)Get full text
Article -
2
P12.03 Heterotypic CD8 T cell clusters isolated from clinical samples are distinct and enriched for antitumor activity by A George, JBAG Haanen, E Mul, S Pack, S Ibáñez Molero, J Veldman, JJH Traets, K Hoefakker, L Tas, P Alóndiga-Mérida, B van den Broek, R Harkes, M Nieuwland, M van Baalen, S Tol, WJv Houdt, DS Peeper
Published in Journal for ImmunoTherapy of Cancer (2024-03-01)Article -
3
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial by S. L. Aronson, B. Thijssen, M. Lopez-Yurda, S. N. Koole, P. van der Leest, A. León-Castillo, R. Harkes, I. M. Seignette, J. Sanders, M. Alkemade, I. Kemper, M. J. Holtkamp, I. A. M. Mandjes, A. Broeks, M. J. Lahaye, M. A. Rijlaarsdam, D. van den Broek, L. F. A. Wessels, H. M. Horlings, W. J. van Driel, G. S. Sonke
Published in Nature Communications (2025-04-01)Get full text
Article
